Currently, as the centralized bulk procurement of pharmaceuticals and medical supplies is being institutionalized and normalized, and as national policies on negotiated drug and medical device pricing continue to deepen, innovation in the IVD sector is accelerating. As a result, clinical access has become a critical factor in the high-quality development of the pharmaceutical and healthcare industry.

As a core cluster and hub for clinical applications in China’s pharmaceutical and healthcare industry, the Beijing-Tianjin-Hebei region has become a vital platform for driving innovation and clinical translation in the pharmaceutical, medical device, and IVD sectors, leveraging its high-quality medical resources, well-developed industrial ecosystem, and policy advantages for pilot initiatives.

To establish a high-end platform for precise alignment between industry and clinical practice, empowering enterprises to grasp policy directions, connect with core resources, and expand market opportunities, the “Beijing-Tianjin-Hebei Pharmaceutical, Medical Device, and IVD Elite Investment Summit,” organized by 8PointHub (Beijing) Health Technology Co., Ltd. and co-organized by HongYiHui (Beijing) Consulting Service Co., Ltd., will be held on March 18, 2026, at the Beijing Yanfengtai Main Branch.

The summit brought together over 1,000 channel distributors and IVD business development professionals, focusing on nationally negotiated pharmaceuticals, innovative medical devices, and in vitro diagnostics (IVD). It served as a platform for deep integration among industry, academia, research, and clinical practice, exploring opportunities for clinical access and market expansion.

Coninno was invited by its partner distributor—Beijing Xinyuan Kerui Biotechnology Co., Ltd., a co-organizer of the event—to showcase its rapid allergen test kits and the CIO-1001 analyzer. The event drew a large crowd of attendees and business partners. During the session, Coninno presented its core technologies and product advantages, receiving unanimous praise from distributors on-site!

Coninno has established one of the few platforms in China that combines rapid and high-throughput allergen-specific IgE testing. The company is committed to providing comprehensive, multi-dimensional allergy service solutions—ranging from allergen screening to the integrated management of allergic diseases and health education. Leveraging its innovative technologies, Coninno has successfully obtained multiple Class II medical device registration certificates and has gained widespread recognition for its clinical applications!

Coninno specializes in rapid allergen testing, offering a convenient and efficient testing process with no waiting time, ensuring a safe and seamless experience. With a variety of test combinations covering a wide range of allergens, we cater to individual needs. Kangyinuo is committed to safeguarding your health with high-quality products, serving as your trusted partner in allergy management.

Behind-the-Scenes Moments

About the 2026 Beijing-Tianjin-Hebei Pharmaceuticals, Medical Devices, and IVD Elite Summit

Under the theme “Focusing on Innovation in Nationally Negotiated Drugs, Medical Devices, and IVDs, and Aligning with Core Clinical Access Requirements,” the summit leverages the advantages of the Beijing-Tianjin-Hebei region as a core hub for the pharmaceutical and healthcare industry. It establishes a platform for precise collaboration among industry, academia, research institutions, and end-users, bringing together over 1,000 channel distributors, IVD business development professionals, and more than 200 specially invited guests. Through policy briefings, product roadshows, exhibition hall networking, and targeted business meetings, the event helped enterprises grasp the policy direction of national drug price negotiations, connect with core resources, and expand their clinical and market reach, thereby driving innovation, commercialization, and high-quality development in the pharmaceutical, medical device, and IVD industries.